General MedicationsINTRAVENOUSStandard
BEIZRAY
DOCETAXEL
Standard Dose
80MG/4ML (20MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview BEIZRAY is listed in Drugs@FDA under application 218711 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DOCETAXEL Form and strength SOLUTION;INTRAVENOUS - 80MG/4ML (20MG/ML) Sponsor ZHUHAI Submission history Latest submission status date: 2025-04-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview BEIZRAY is listed in Drugs@FDA under application 218711 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOCETAXEL Form and strength SOLUTION;INTRAVENOUS - 80MG/4ML (20MG/ML) Sponsor ZHUHAI Submission history Latest submission status date: 2025-04-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.